Delivery Order SPE2DB24D2216-SPE2DB25FGPTQ
- Not listed
- The Defense Logistics Agency awarded a $25,734.37 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with completion scheduled for September 4, 2025. This contract utilizes a firm fixed price structure and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $11,557.43 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a contract value of $6,473.57 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $7,726.10 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract involves the supply of a specific pharmaceutical product for federal medical...
- The Defense Logistics Agency awarded a $3,252.20 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $2,729.66 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance is scheduled to conclude by July 24, 2025, with fulfillment occurring at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $20,724.74. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical procurement through DLA's medical supply chain to support federal...
- The Defense Logistics Agency awarded a $3,484.71 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation through open competition. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $6,578.04. This competitively awarded, firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement under AmerisourceBergen's broader federal...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPTQDelivery Order
The Defense Logistics Agency awarded a $21,169.40 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's headquarters in Conshohocken, Pennsylvania. The award represents a single delivery of this insulin pharmaceutical product to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceuticals and medical commodities to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal healthcare vendor and has demonstrated capability to meet competitive federal procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialized medical supplies for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 9/10/25 |